Single use Bioreactors Market

The report "Single use Bioreactors Market Size, Growth by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (R&D, Process Development), End User (Biopharma, CROs & CMOs) - Global Forecast to 2026", is projected to reach USD 8.8 billion by 2026, at a CAGR of 21.1%.

Browse 235 market data Tables and 32 Figures spread through 207 Pages and in-depth TOC on "Single-use Bioreactors Market - Global Forecast to 2026"
View detailed Table of Content here -https://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html

Single-use bioreactor systems accounted for the largest share of single-use bioreactors market

Based on product, the single-use bioreactors market is categorized into single-use bioreactor systems, single-use media bags, single-use filtration assemblies, and other products such as single-use vessels, tubing, connectors, control systems, and probes/sensors, among others. The single-use bioreactor systems segment dominated the single-use bioreactors market. Disposable bioreactors are based on single-use technology, which uses disposable equipment to manufacture biopharmaceutical products. One of the biggest advantages of single-use bioreactor systems is their flexibility. The increasing trend towards multi-drug facilities demands the production of different drugs using the same facility, with minimum time and cost and without compromising the quality of the drug.

Stirred-tank SUBs accounted for the largest share of single-use bioreactors market

Based on type, the single-use bioreactors market is categorized into wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors such as hybrid bioreactors and SUBs with vertically perforated discs. The stirred-tank SUBs segment dominated the single-use bioreactors market. The use of stirred-tank SUBs reduces engineering challenges such as heat removal and O2 mass transfer. These single-use bioreactors have higher agitation rates that positively impact cell viability and glucose consumption rates. This has contributed to the overall growth of this segment.

The contract research organizations (CROs) and contract manufacturing organizations (CMOs) is the fastest-growing end user segment of the single-use bioreactors market

Based on end users, the single-use bioreactors market is segmented into pharmaceutical & biopharmaceutical companies, contract research organizations and contract manufacturing organizations (CROs and CMOs), and academic & research institutes. The CROs and CDMOs segment is set to grow at the fastest pace during the forecast period. Contract research organizations (CROs) and contract manufacturing organizations (CMOs) provide various services to pharmaceutical and biopharmaceutical companies on a contract basis, including drug discovery and development, clinical scale manufacturing, preclinical and clinical trials, and commercial manufacturing. Pharmaceutical companies are emphasizing outsourcing their R&D services to reduce operational costs, which is expected to drive the segment growth.

North America accounted for the largest share of the single-use bioreactors market

North America accounted for the largest share of the single-use bioreactors market, followed by Europe. Many players operating in the single-use bioreactors market, such as Danaher, Thermo Fisher Scientific, Distek, and ABEC, have a strong presence in North America, with a wide customer base and established distribution channels. This has contributed to the dominance of the North America region in the SUB market.

The prominent players operating in the single-use bioreactors market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany).

Don’t miss out on business opportunities in Single-use Bioreactors Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]